Trial Profile
A prospective randomized controlled trial of roxadustat for the first recipient to alleviate delayed graft function and acute rejection after renal transplantation
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2020
Price :
$35
*
At a glance
- Drugs Roxadustat (Primary)
- Indications Delayed graft function; Renal transplant rejection
- Focus Therapeutic Use
- 05 Aug 2020 New trial record